Similar articles

• [Treatment of benign prostatic hypertrophy].

  Romics I. Romics I. Orv Hetil. 2003 Nov 9;144(45):2229-30. Orv Hetil. 2003. PMID: 14686009 Review. Hungarian. No abstract available.
• Evaluation and medical management of benign prostatic hyperplasia.

  Beckman TJ, Mynderse LA. Beckman TJ, et al. Mayo Clin Proc. 2005 Oct;80(10):1356-62. doi: 10.4065/80.10.1356. Mayo Clin Proc. 2005. PMID: 16212149
• Managing benign prostatic hyperplasia.

  Garnett S, Abrams P. Garnett S, et al. Practitioner. 2001 Oct;245(1627):830-2, 834, 836 passim. Practitioner. 2001. PMID: 11677898 Review. No abstract available.
• The effects of 5α-reductase inhibition on benign prostatic hyperplasia treated by photoselective vaporization prostatectomy with the 120 Watt GreenLight HPS laser system.

  Strom KH, Gu X, Spaliviero M, Wong C. Strom KH, et al. J Am Coll Surg. 2011 Feb;212(2):244-50. doi: 10.1016/j.jamcollsurg.2010.09.029. Epub 2010 Dec 23. J Am Coll Surg. 2011. PMID: 21183365
• Assessment of the patient with benign prostatic hyperplasia.

  Carlin BI, Resnick ML. Carlin BI, et al. Compr Ther. 1996 Sep;22(9):586-91. Compr Ther. 1996. PMID: 8902350 Review. No abstract available.